Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.

Blood·2026
Same author

Persistent IFN-I signaling inhibits mitochondrial oxidative metabolism in CD8<sup>+</sup> T cells during HIV-1 infection under cART.

Cellular & molecular immunology·2026
Same author

HEPLISAV-B Breaks Immune Tolerance and Induces HBV Control via CD4 T Cell-Dependent Mechanisms in a Chronic Hepatitis B Mouse Model.

bioRxiv : the preprint server for biology·2026
Same author

Depletion of plasmacytoid dendritic cells rescues HIV-reactive stem-like CD8<sup>+</sup> T cells during chronic HIV-1 infection.

Science translational medicine·2025
Same author

Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART.

Viruses·2025
Same author

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy.

Science translational medicine·2023
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.3K

Advancing Human Vaccine Development Using Humanized Mouse Models.

Runpeng Han1,2, Lishan Su3, Liang Cheng1,2

  • 1Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan 430071, China.

Vaccines
|September 28, 2024
PubMed
Summary
This summary is machine-generated.

Humanized mice (hu-mice) models offer a better way to test human vaccines by mimicking human immune responses. This review explores their use in vaccine development, especially for HIV-1, and discusses future improvements.

Keywords:
HIV-1human vaccinehumanized miceinfectious diseases

More Related Videos

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.5K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.0K

Related Experiment Videos

Last Updated: Jun 11, 2025

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
05:15

Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery

Published on: September 27, 2021

1.3K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.5K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.0K

Area of Science:

  • Immunology
  • Vaccinology
  • Preclinical Research

Background:

  • Developing effective vaccines for infectious diseases is a global health priority.
  • Traditional animal models often fail to accurately predict human immune responses to vaccines.
  • Humanized mice (hu-mice) offer a promising solution by incorporating a functional human immune system.

Purpose of the Study:

  • To review commonly used hu-mice models and advancements in their optimization for improved human immune responses.
  • To summarize the application of hu-mice in human vaccine development, with a specific focus on HIV-1 vaccines.
  • To identify remaining challenges and necessary improvements for hu-mice models in vaccine research.

Main Methods:

  • Review of existing literature on hu-mice models.
  • Analysis of studies utilizing hu-mice for vaccine efficacy and safety testing.
  • Discussion of strategies for enhancing human immune system reconstitution in mice.

Main Results:

  • Hu-mice models provide a more relevant preclinical platform for evaluating human vaccine candidates.
  • Significant progress has been made in optimizing hu-mice to better mimic human immune responses.
  • Applications in HIV-1 vaccine development highlight the potential of these models.

Conclusions:

  • Hu-mice models are crucial for bridging the translational gap in human vaccine development.
  • Further refinements are needed to fully realize the potential of hu-mice for diverse infectious disease vaccine testing.
  • Optimized hu-mice models are essential for accelerating the development of safe and effective human vaccines.